Download the Advisory Brief: ‘What You Need to Know to be Prepared for 2023: Highlights from TGaS Advisors’ Fall Summit’ to understand the data behind the insights delivered in this podcast: https://bit.ly/3g8btP7 ____________________ Host and President of TGaS Advisors, Gary McWalters, joins a panel of four experts from TGaS Advisors, a division of Trinity Life Sciences, to discuss the key themes that were discussed at the TGaS Fall Client Summit – an annual event that brings together leaders in life sciences to discuss innovative solutions to the common challenges faced within commercial operations. Expert Panel: Kim Woodhour | Field Operations Director Brian Voellmecke | Commercial Data Management Leader Jim Castello | Incentive Compensation Leader Ken McDermott | Executive Commercial Operations Leader Key Topics of Discussion: The evolution of the commercial model in life sciences Capabilities that organizations need to keep pace with change Identifying the right key performance metrics How leaders of life sciences should prepare for 2023

Download the White Paper: Diversity in Clinical Trials Participation: A Life Sciences Perspective | https://bit.ly/3LQRFeq ____________________ The importance of ensuring diversity in clinical trials is undisputed, but barriers across the healthcare ecosystem still exist; what can healthcare regulators, policy makers, and manufacturers do to overcome challenges when recruiting clinical trial participants? Host, Matthew Rube, a Senior Consultant at Trinity Life Sciences, joins two of the subject-matter experts who authored Trinity Life Sciences’ cornerstone white paper (Michele Andrews - Principal, Strategic Advisory and Head of Dynamic Market Intelligence, and Monique Marsh - Associate Director of Primary Market Research and Head of Qualitative Innovation and Implementation) to discuss why ensuring diversity in clinical trials participation is such a critical issue, the results of the team’s research, and the action-oriented recommendations that they have for the life sciences industry. ____________________ Thank you to everyone who contributed towards this important research: Peter Palumbo, Patrick Hong, Monique Marsh, Shanice O’Brien, Courtney Poopat, Catherine Toal, Michele Andrews, Herman Sanchez, Sumudu Dehipawala, UT Yadav, Alexander Fish, Peter Baek, Alessandra Moscoso, Shruti Nambiar, and Justin Li

Download the Advisory Brief: Capitalizing on Opportunities to Drive Impact in Commercial Operations |https://bit.ly/3IFUZra _______________________________________ In the wake of the COVID-19 pandemic, pharmaceutical companies have needed to pivot in the way they operate so that they can keep information flowing to providers and patients. Commercial Operations functions have since been capitalizing on opportunities to enhance their capabilities and drive impact across their organizations. Host and Executive Commercial Operations Leader, Ken McDermott, joins a panel of three experts from TGaS Advisors, a division of Trinity Life Sciences, to discuss the shifting priorities as commercial teams work to evolve virtual and digital channels to engage with customers and sharpen advanced analytics. Expert Panel:  Lisa Klein | Vice President, Field Operations Jerry Luciano | Vice President, Digital and Omnichannel Solutions Steve Laux | Vice President, Commercial Insights and Advanced Analytics Solutions Download the Advisory Brief: Read Trinity Life Sciences’ advisory brief 'Capitalizing on Opportunities to Drive Impact in Commercial Operations’to understand the data behind the insights based on Trinity’s work with 2000+ individuals across 300 partner companies, and the key themes that emerged during our 2022 Spring Virtual Client Summit.